with

Riyadh International Philosophy Conference 2024 Concludes with a Focus on Quality of Life

Day 3 explored the philosophical contributions to the quality of life, and the ethical implications of AI and its impact…

4 days ago

Embitel continues its journey with the Volkswagen Group, advancing toward a brighter digital future

BENGALURU, India, Dec. 7, 2024 /PRNewswire/ -- Embitel Technologies, a globally recognized provider of cutting-edge product engineering services and end-to-end digital…

4 days ago

Deepak Nitrite Chairman & Managing Director, Shri Deepak C Mehta, Honored with ICC Lifetime Achievement Award for 2023

•  Recognized for Outstanding Contribution to Chemical Manufacturing at the 59th ICC Annual Awards in Mumbai VADODARA, India, Sept. 26,…

4 days ago

Automechanika Dubai supports the UAEs eMobility goals with a platform for innovation and collaboration

The Innovation4Mobility Conference at Automechanika Dubai will highlight the technologies, policies, and partnerships that are accelerating the adoption of electric…

5 days ago

Investigational Epcoritamab (DuoBody CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Media ReleaseCOPENHAGEN, Denmark; December 7, 2024 Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and…

5 days ago

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease…

5 days ago

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ and Its Impact on Blood Cancer Treatment Decisions

New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies…

5 days ago

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity…

5 days ago

BOULT Expands Retail Footprint with Cashify Partnership Across India

NEW DELHI, Dec. 6, 2024 /PRNewswire/ -- BOULT, India's No. 1 rated audio brand, today announced a long-term strategic partnership…

5 days ago

SR_A HUBLOT 3.0 IN PARTNERSHIP WITH DR SAMUEL ROSS MBE

Faithful to Hublot's 'Art of Fusion', the brilliant artist and designer Samuel Ross takes his creativity to new heights through considered…

5 days ago